Chubb Reports Tonight With Profit Expected Down 17%
CB is up about 5% in a week heading into Tuesday’s release, leaving little cushion if catastrophe losses or the accident-year ratio disappoint.
Headlines
7.5% Mortgages in 2027 Will Cost Buyers More Per Month
Fannie Mae’s sharp forecast revision reshapes the math for buyers, refinancers, and homebuilder stocks.
The Hidden Toll Booth Inside Every Desalination Plant
Energy recovery devices can cut reverse osmosis power use by up to 60%. One U.S. supplier just signed a third major contract in weeks.
The ECB’s September Hike Looked Unanimous. The Account May Tell a Different Story.
European shares and the euro are under pressure as the ECB publishes what the Governing Council argued behind closed doors.
600,000 Seniors Got Humana Non-Renewal Letters This Week. Here Is What to Do Before October 15.
The Medicare Advantage shakeout is the largest in years — and it tells investors something important about owning UnitedHealth and Humana shares.
PayPal Has a New Suitor. Here Is What the Business Is Worth.
Strip out the deal premium and the underlying assets look more complicated than either bulls or bears want to admit.
Wendy’s Biggest Franchisee Just Went Bankrupt. Is Your ‘Safe’ Fast-Food Stock Safe?
The Meritage collapse exposes a fault line beneath fast-food defensiveness.
Moderna’s Cancer Factory Is the Real Story
A Phase 3 melanoma win proves mRNA oncology. Can it scale?
Zcash Hits $1,400 While Bitcoin Loses Ground in 2026
The Fed’s first rate hike since 2023 barely dented ZEC. Bitcoin still can’t reclaim its January open.
Holtec Nuclear Pulled Its $900 Million IPO. Still Worth Watching.
HNUC shelved its listing as the Fed hiked, and its real revenue base sets it apart.